» Articles » PMID: 16205969

Selection of Optimal Host Strain for Molecular Pathogenesis Studies on Cryptococcus Gattii

Overview
Journal Mycopathologia
Date 2005 Oct 6
PMID 16205969
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Encapsulated yeast, Cryptococcus gattii (Cg) is a primary and emerging fungal pathogen in North America. It has a predilection for invading the central nervous system of both healthy and immunocompromised humans and animals. Recently, we initiated molecular pathogenesis studies in Cg strain NIH444 (ATCC 32609). In this report, we compared the biology and pathogenic potential of NIH444 to those of WM276, an Australian environmental isolate that is being used for the whole genome-sequencing project. Our data indicated that NIH444 is comparatively more virulent in a mouse model of cryptococcosis than is WM 276. We found robust mating of NIH444, and no mating of WM276, when tested against Cg MATa strain, NIH198. WM276 but not NIH444 was defective in filamentation and sporulation (haploid fruiting). Interestingly, NIH444 has a VGII/AFLP6 genotype similar to that of the genotype of the recent outbreak strains from Vancouver Island, British Columbia, Canada. Additionally, comparisons of nucleotide sequences of various genes also showed differences between NIH444 and WM276. Based on these observations, we conclude that NIH444 should remain the strain of choice for understanding Cg pathogenesis, especially on the North American continent.

Citing Articles

Quantitative MRI of a Cerebral Cryptococcoma Mouse Model for In Vivo Distinction between Different Cryptococcal Molecular Types.

Musetta L, Helsper S, Roosen L, Maes D, Croitor Sava A, Vanherp L J Fungi (Basel). 2024; 10(8).

PMID: 39194918 PMC: 11355240. DOI: 10.3390/jof10080593.


Population Genetic Analysis Reveals a High Genetic Diversity in the Brazilian Cryptococcus gattii VGII Population and Shifts the Global Origin from the Amazon Rainforest to the Semi-arid Desert in the Northeast of Brazil.

Souto A, Bonfietti L, Ferreira-Paim K, Trilles L, Martins M, Ribeiro-Alves M PLoS Negl Trop Dis. 2016; 10(8):e0004885.

PMID: 27529479 PMC: 4986980. DOI: 10.1371/journal.pntd.0004885.


Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal.

Springer D, Billmyre R, Filler E, Voelz K, Pursall R, Mieczkowski P PLoS Pathog. 2014; 10(8):e1004285.

PMID: 25144534 PMC: 4140843. DOI: 10.1371/journal.ppat.1004285.


Congenic strains for genetic analysis of virulence traits in Cryptococcus gattii.

Zhu P, Zhai B, Lin X, Idnurm A Infect Immun. 2013; 81(7):2616-25.

PMID: 23670558 PMC: 3697594. DOI: 10.1128/IAI.00018-13.


Cryptococcus gattii comparative genomics and transcriptomics: a NIH/NIAID White Paper.

Chaturvedi V, Nierman W Mycopathologia. 2011; 173(5-6):367-73.

PMID: 22179781 DOI: 10.1007/s11046-011-9512-9.


References
1.
Dong Z, Murphy J . Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun. 1995; 63(7):2632-44. PMC: 173353. DOI: 10.1128/iai.63.7.2632-2644.1995. View

2.
Fisher D, Burrow J, Lo D, Currie B . Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust N Z J Med. 1993; 23(6):678-82. DOI: 10.1111/j.1445-5994.1993.tb04726.x. View

3.
Stephen C, Lester S, Black W, Fyfe M, Raverty S . Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J. 2002; 43(10):792-4. PMC: 339618. View

4.
Klittich C, Leslie J . Nitrate reduction mutants of fusarium moniliforme (gibberella fujikuroi). Genetics. 1988; 118(3):417-23. PMC: 1203296. DOI: 10.1093/genetics/118.3.417. View

5.
Cox G, McDADE H, Chen S, Tucker S, Gottfredsson M, Wright L . Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol. 2000; 39(1):166-75. DOI: 10.1046/j.1365-2958.2001.02236.x. View